Numeric aberration of chromosome 17 is strongly correlated with p53 overexpression, tumor proliferation and histopathology in human bladder cancer

International Journal of Urology

Volumn 5, Issue 4, 1998, Pages 317-323

  Li, Benyi ^a   Kanamaru, Hiroshi ^a   Noriki, Sakon ^a   Fukuda, Masaru ^a   Okada, Kenichiro ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Bladder cancer; Chromosome 17; In situ hybridization; p53; PCNA immunohistochemistry

Indexed keywords

CYCLINE; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CANCER; CHROMOSOME 17; CHROMOSOME ABERRATION; DNA PROBE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERPHASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

EID: 0031706080     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1998.tb00358.x     Document Type: Article

References (18)

1. Culter SJ, Heney NM, Friedell GH. Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression. In: Bonney WW, Prout GR (eds) Bladder cancer. AUA Monographs. Baltimore: Williams & Wilkins, 1982:35-46.
2. Tribukait B, Granberg-Ohman I, Wijkstrom H. Flow cytometric DNA and cytogenetic studies in human tumors: a comparison and discussion of the differences in modal values obtained by two methods. Cytometry 1986;7:194-199.
3. Sandberg AA, Berger CS. Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol 1994;151:545-549.
4. Olumi AF, Tsai YC, Nichols PW, Skinner DG, Gain DR, Bender LI, Jones PA. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res 1990;50:7081-7083.
5. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1989;83:2934-2938.
6. Nemoto R, Nakamura K, Uchida K, Harada M. Numeric chromosome aberrations in bladder cancer detected by in situ hybridization. Br J Urol 1995;75:470-476.
7. Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 1991;51:3807-3813.
8. Hopman AHN, Moesker O, Smeets AWGB, Pauwels RPF, Vooijs GP. Numeric chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 1991;51:644-651.
9. The Japanese Urological Association and the Japanese Society of Pathology. The general rules for clinical and pathological studies on bladder cancer. 2nd ed. Tokyo: Kanehara, 1992.
10. Hopman AH, Poddighe P, Moesker O, Ramaekes FC. Interphase cytogenetics: an approach to the detection of genetic aberrations in tumors. In: Herrington CS, McGee JO'D (eds) Diagnostic molecular pathology: a practical approach. Oxford: Oxford University Press, 1992;1:141-167.
11. Hsu SM, Rainne L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;27:577-582.
12. Lane D. p53, guardian of the genome. Nature 1992;358: 15-16.
13. Serth J, Kuczyk MA, Bokemeyer C, Hervatin C, Nafe R, Tan HK, Jones U. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer 1995;71:201-205.
14. Esrig D, Spruck CH III, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 1993;143:1389-1392.
15. Sauter G, Moch H, GasserTC, Mihatsch MJ, Waldman FM. Heterogeneity of chromosome 17 and crbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry 1995;21:40-46.
16. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-764.
17. Ishikawa J, Xu HJ,Yandell DW, Maeda S, Kamidono S, Benedict WF, Takahashi R. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinoma. Cancer Res 1991;51:5736-5740.
18. Borland RN, Brendler RN, Isaac WB. Molecular biology of bladder cancer. Hematol Oncol Clin N Am 1992;6:31 36.